Endocrine risk factors of endometrial cancer: polycystic ovary syndrome, oral contraceptives, infertility, tamoxifen
A Ignatov, O Ortmann - Cancers, 2020 - mdpi.com
Endometrial cancer is the most common gynecologic cancer and is predominantly
endocrine-related. The role of unopposed estrogen in the development of endometrial …
endocrine-related. The role of unopposed estrogen in the development of endometrial …
The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence
R Troisi, T Bjørge, M Gissler, T Grotmol… - Journal of internal …, 2018 - Wiley Online Library
An understanding of the origin of cancer is critical for cancer prevention and treatment.
Complex biological mechanisms promote carcinogenesis, and there is increasing evidence …
Complex biological mechanisms promote carcinogenesis, and there is increasing evidence …
Bokhman Redux: Endometrial cancer “types” in the 21st century
Abstract In 1983 Jan V. Bokhman, MD published a landmark paper entitled “Two
Pathogenetic Types of Endometrial Carcinoma” in which an enduring dualistic view of …
Pathogenetic Types of Endometrial Carcinoma” in which an enduring dualistic view of …
Incidence of cancer in adolescent idiopathic scoliosis patients treated 25 years previously
A Simony, EJ Hansen, SB Christensen… - European Spine …, 2016 - Springer
Purpose To report the incidence of cancer in a cohort of adolescent idiopathic scoliosis (AIS)
patients treated 25 years previously. Methods 215 consecutive AIS patients treated between …
patients treated 25 years previously. Methods 215 consecutive AIS patients treated between …
[HTML][HTML] Endometrial biopsy: Indications, techniques and recommendations. An evidence-based guideline for clinical practice
SG Vitale, G Buzzaccarini, G Riemma… - Journal of gynecology …, 2023 - Elsevier
This practice guideline provides updated evidence for the gynecologist who performs
endometrial biopsy (EB) in gynecologic clinical practice. An international committee of …
endometrial biopsy (EB) in gynecologic clinical practice. An international committee of …
Cancer progress and priorities: uterine cancer
AS Felix, LA Brinton - Cancer Epidemiology, Biomarkers & Prevention, 2018 - AACR
Background Uterine corpus cancer is the most common invasive gynecologic cancer among
US women. Studies of endometrial cancers, which comprise approximately 90% of all …
US women. Studies of endometrial cancers, which comprise approximately 90% of all …
Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences
AS Felix, HP Yang, DW Bell, ME Sherman - Molecular Genetics of …, 2017 - Springer
Endometrial carcinoma is the most common gynecologic cancer in developed nations, and
the annual incidence is projected to increase, secondary to the high prevalence of obesity, a …
the annual incidence is projected to increase, secondary to the high prevalence of obesity, a …
The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study
FE Lundberg, AN Iliadou, K Rodriguez-Wallberg… - European journal of …, 2019 - Springer
Some studies have suggested that infertility is a risk factor for endometrial, ovarian and
breast cancer. The study aimed to create a comprehensive picture of the association …
breast cancer. The study aimed to create a comprehensive picture of the association …
[HTML][HTML] Endometrial cancer
H Mahdy, MJ Casey, D Crotzer - 2018 - europepmc.org
Objectives: Identify the epidemiology of endometrial carcinoma. Describe the appropriate
evaluation for a patient with suspected endometrial carcinoma. Describe the treatment …
evaluation for a patient with suspected endometrial carcinoma. Describe the treatment …
Risk of endometrial cancer in women treated with ovary‐stimulating drugs for subfertility
A Skalkidou, TN Sergentanis… - Cochrane Database …, 2017 - cochranelibrary.com
Background Medical treatment for subfertility principally involves the use of ovary‐
stimulating agents, including selective oestrogen receptor modulators (SERMs), such as …
stimulating agents, including selective oestrogen receptor modulators (SERMs), such as …